Changing epidemiology of infections in patients with neutropenia and cancer: Emphasis on gram-positive and resistant bacteria

Clinical Infectious Diseases

Volumn 29, Issue 3, 1999, Pages 490-494

  Zinner, Stephen H ^a,b  

^a BROWN UNIVERSITY   (United States)

^b MOUNT AUBURN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; ANTIBIOTIC AGENT; CEFALEXIN; CEFEPIME; CEFPROZIL; CEFTAZIDIME; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; CYTARABINE; ERYTHROMYCIN; GENTAMICIN; GLYCOPEPTIDE; HISTAMINE H2 RECEPTOR ANTAGONIST; IMIPENEM; METRONIDAZOLE; PENEM DERIVATIVE; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; QUINOLONE; RIFAMPICIN; SULFONAMIDE; TETRACYCLINE; TICARCILLIN; TRIMETHOPRIM; UNINDEXED DRUG; UREIDOPENICILLIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACILLUS CEREUS; BARTONELLACEAE; BURKHOLDERIA CEPACIA; CANCER; CORYNEBACTERIUM; ESCHERICHIA COLI; FEBRILE NEUTROPENIA; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; INFECTION; LEUCONOSTOC; MORAXELLA CATARRHALIS; MUCOSA INFLAMMATION; PRIORITY JOURNAL; RHODOCOCCUS; ROTHIA; STENOTROPHOMONAS MALTOPHILIA;

EID: 0032872308     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/598620     Document Type: Article

References (38)

1. Schimpff SC, Satterlee W, Young VM, Serpick A. Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia. N Engl J Med 1971;284:1061-5.
2. Cometta A, Zinner S, deBock R, et al. Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. Antimicrob Agents Chemother 1995;39:445-52.
3. Cometta A, Calandra T, Gaya H, et al. Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. Antimicrob Agents Chemother 1996;40:1108-18.
4. Gonzalez-Barca E, Fernandez-Sevilla A, Carratala J, Granena A, Gudiol F. Prospective study of 288 episodes of bacteremia in neutropenic cancer patients in a single institution. Eur J Clin Microbiol Infect Dis 1996; 15:291-6.
5. Richard P, Del Valle GA, Moreau P, et al. Viridans streptococcal bacteraemia in patients with neutropenia. Lancet 1995;345:1607-9.
6. Elting LS, Bodey GP, Keefe BH. Septicemia and shock syndrome due to viridans streptococci: a case-control study of predisposing factors. Clin Infect Dis 1992;14:1201-7.
7. Cruciani M, Rampazzo R, Malena M, et al. Prophylaxis with fluoroquinolones for bacterial infections in neutropenic patients: a meta-analysis. Clin Infect Dis 1996;23:795-805.
8. Engels EA, Lau J, Barza M. Efficacy of quinolone prophylaxis in neutropenic cancer patients: a meta-analysis. J Clin Oncol 1998;16:1179-87.
9. Kilton LJ, Fossieck BE Jr, Cohen MH, Parker RH. Bacteremia due to gram-positive cocci in patients with neoplastic disease. Am J Med 1979;66:596-602.
10. Arning M, Gehrt A, Aul C, Runde V, Hadding U, Schneider W. Septicemia due to Steptococcus mitis in neutropenic patients with acute leukemia. Blut 1990;61:364-8.
11. Engel A, Kern P, Kern WV. Levels of cytokines and cytokine inhibitors in the neutropenic patient with α-hemolytic streptococcus shock syndrome. Clin Infect Dis 1996;23:785-9.
12. Doem GV, Ferraro MJ, Brueggemann A, Ruoff KL. Emergence of high rates of antimicrobial resistance among viridans group streptococci in the United States. Antimicrob Agents Chemother 1996;40:891-4.
13. Pfaller MA, Marshall SA, Jones RN. In vitro activity of cefepime and ceftazidime against 197 nosocomial blood stream isolates of streptococci: a multicenter sample. Diagn Microbiol Infect Dis 1997;29:273-6.
14. Bantar C, Fernandez Canigia L, Relloso S, Lanza A, Bianchini H, Smayevsky J. Species belonging to the "Streptococcus milleri" group: antimicrobial susceptibility and comparative prevalence in significant clinical specimens. J Clin Microbiol 1996;34:2020-2.
15. Balkundi DR, Murray DL, Patterson MJ, Gera R, Scott-Emuakpor A, Kulkami R. Penicillin-resistant Streptococcus mitis as a cause of septicemia with meningitis in febrile neutropenic children. J Pediatr Hematol Oncol 1997;19:82-5.
16. Edmond MC, Ober JF, Weinbaum DL, et al. Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection. Clin Infect Dis 1995;20:1126-33.
17. Handwerger S, Horowitz H, Coburn K, Kolokathis A, Wormser GP. Infection due to Leuconostoc species: six cases and review. Rev Infect Dis 1990;12:602-10.
18. Stamm WE, Tompkins LS, Wagner KF, Counts GW, Thomas ED, Meyers JD. Infections due to Corynebacterium species in marrow transplant patients. Ann Intern Med 1979;91:167-73.
19. Van der Lelie H, Leversteinvanhall M, Mertens M, et al. Corynebacterium CDC group JK (Corynebarterium jeikeium) sepsis in haematological patients: a report of three cases and a systematic literature review. Scand J Infect Dis 1995;27:581-4.
20. Saavedra J, Rodriguez JN, Fernandez-Jurrado A, Vega MD, Pascual L, Prados D. A necrotic soft-tissue lesion due to Corynebacterium ureatyticum in a neutropenic child. Clin Infect Dis 1996;22:851-2.
21. Harvey RI, Sunstrum JC. Rhodococcus equi infection in patients with and without human immunodeficiency virus infection. Rev Infect Dis 1991; 13:139-45.
22. Asher DP, Zbick C, White C, Fischer GW. Infections due Stomatococcus mucilaginosus; 10 cases and review. Rev Infect Dis 1991;13: 1048-52.
23. McWhinney PHM, Kibbler CC, Gillespie SH, et al. Stomatoccus mucilaginosus: an emerging pathogen in neutropenic patients. Clin Infect Dis 1992;14:641-6.
24. Henrickson KJ, Shenep JL, Flynn PM, Pui CH. Primary cutaneous Racillus cereus infection in neutropenic children. Lancet 1989;1:601-3.
25. Kremery V, Pichna P, Oravcova E, et al. Stenotrophomonas maltophilia bacteremia in cancer patients: report on 31 cases. J Hosp Infect 1996; 34:75-7.
26. Dobroszycki J, Sklarin NT, Szilagy G, Tanowitz HB. Vibrio parahaemolyticus septicemia in a patient with neutropenic leukemia [letter]. Clin Infect Dis 1992;15:738-9.
27. Bilgrami S, Bergstrom SK, Peterson DE, et al. Capnocytophaga bacteremia in a patient with Hodgkin's disease following bone marrow transplantation: case report and review. Clin Infect Dis 1992;14:1045-9.
28. Knippschild M, Schmid EN, Uppenkamp M, et al. Infection by Alculigenes xylosoxidans subsp. xylosoxidans in neutropenic patients. Oncology 1996;53:258-62.
29. Bloch KC, Nadarajah R, Jacobs R. Chryseobacterium meningosepticum; an emerging pathogen among immunocompromised adults. Medicine 1997;76:30-41.
30. Pegues DA, Carson LA, Anderson RL, et al. Outbreak of Pseudomonas cepacia bacteremia in oncology patients. Clin Infect Dis 1993;16: 407-11.
31. Huyghebaert MF, Dreyfus F, Paul G, et al. Septicémie á Fusobacterium nucleatum, producteur de beta-lactamase chez un sujet neutropénique. Ann Med Interne (Paris) 1989;140:225-6.
32. Weinberger M, Wu T, Rubin M, Gill VJ, Pizzo PA. Leptotrichia buccalis bacteremia in patients with cancer: report of four cases and review. Rev Infect Dis 1991;13:201-6.
33. Kern WV, Andriof E, Oethinger M, Kern P, Hacker J, Marre R. Emergence of fluoroquinolone-resistant Escherichia coli at a cancer center. Antimicrob Agents Chemother 1994;38:681-7.
34. Cometta A, Calandra T, Bille J, Glauser MP. Escherichia coli resistant to fluoroquinolones in patients with cancer and neutropenia [letter]. N Engl J Med 1994;330:1240-1.
35. Oethinger M, Conrad S, Kaifel K, et al. Molecular epidemiology of fluoroquinolone-resistant Escherichia coli bloodstream isolates from patients admitted to European cancer centers. Antimicrob Agents Chemother 1996;40:387-92.
36. Carratala J, Fernandez-Sevilla A, Tubau FE, Angeles-Dominguez M, Gudiol F. Emergence of fluoroquinolone-resistant Escherichia coli in fecal flora of cancer patients receiving norfloxacin prophylaxis. Antimicrob Agents Chemother 1996;40:503-5.
37. Kunova A, Trupl J, Kremery V. Low incidence of quinolone resistance in gram-negative bacteria after five years use of ofloxacin in prophylaxis during afebrile neutropenia. J Hosp Infect 1996;32:155-6.
38. Nucei M, Spector N, Lucena S, et al. Three cases of infection with Fusarium species in neutropenic patients. Eur J Clin Microbiol Infect Dis 1992;11:1160-2.